New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents
Ara Metjian1, Charles S Abrams21Department of Medicine, Duke University Medical Center, Durham, NC, USA; 2Department of Medicine, University of Pennsylvania, Philadelphia, PA, USAAbstract: Decades of basic science and clinical research have led to an increased understanding of the pathophysiology of...
Guardado en:
Autores principales: | Ara Metjian, Charles S Abrams |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/74cf4975d3a343f5966897488f73a8f1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
THE OUTCOME OF IMMUNE THROMBOCYTOPENIC PURPURA IN CHILDHOOD AND THE RISK FACTORS FOR CHRONICITY
por: Barış YILMAZ, et al.
Publicado: (2021) -
Treatment of immune thrombocytopenic purpura: focus on eltrombopag
por: Lawrence Rice
Publicado: (2009) -
Emerging Concepts in Immune Thrombotic Thrombocytopenic Purpura
por: Aicha Laghmouchi, et al.
Publicado: (2021) -
Management of chronic immune thrombocytopenic purpura: targeting insufficient megakaryopoiesis as a novel therapeutic principle
por: Andreas Rank, et al.
Publicado: (2010) -
THROMBOTIC THROMBOCYTOPENIC PURPURA: OUR CLINICAL EXPERIENCE
por: Zahid Farooq Baig, et al.
Publicado: (2018)